Conditional Survival in Anal Carcinoma Using the National Population-Based Survey of Epidemiology and End Results Database (1988-2012)

Ellen Kim, Jong S. Kim, Mehee Choi, Charles Thomas

Research output: Contribution to journalArticle

5 Citations (Scopus)

Abstract

BACKGROUND: Conditional survival can provide valuable information for both patients and healthcare providers about the changing prognosis in surviving patients over time. OBJECTIVE: This study estimated conditional survival for patients with anal cancer in the United States through analysis of a national population-based cancer registry. DESIGN: Log-rank test identified significant covariates of cause-specific survival (defined as time from diagnosis until death from anal cancer). Significant covariates were considered in the multivariable regression of cause-specific survival using Cox proportional hazards models. SETTINGS: Covariates included cancer stage and demographic variables. PATIENTS: Patients in Surveillance, Epidemiology, and End Results regions diagnosed with anal squamous cell carcinoma as their first and only cancer diagnosis from 1988 to 2012 were selected from this database, and 5145 patients were included in the retrospective cohort study. MAIN OUTCOME MEASURE: Five-year conditional survival stratified by each variable in the final Cox models was measured RESULTS: The final multivariable models of overall and cause-specific survivals included stage, grade, sex, age, race, and relationship status. Over the first 6 years after diagnosis, conditional survival of distant stage increased from 37% to 89%, whereas regional stage increased from 65% to 93% and localized stage increased from 84% to 96%. The other variables had increasing prognosis as well, but the subgroups increased at a more similar rate over time. LIMITATIONS: The data source used does not include information on chemotherapy treatment, patient comorbidities, or socioeconomic status. CONCLUSIONS: Conditional survival showed improvement over time. Patients with advanced stage had the greatest improvement in conditional survival. This is the first study to provide specific conditional survival probabilities for patients with anal cancer.

Original languageEnglish (US)
Pages (from-to)291-298
Number of pages8
JournalDiseases of the Colon and Rectum
Volume59
Issue number4
DOIs
StatePublished - Apr 1 2016

Fingerprint

Epidemiology
Databases
Carcinoma
Survival
Population
Anus Neoplasms
Proportional Hazards Models
Surveys and Questionnaires
Neoplasms
Information Storage and Retrieval
Social Class
Health Personnel
Registries
Comorbidity
Squamous Cell Carcinoma
Cohort Studies
Retrospective Studies
Demography
Drug Therapy

Keywords

  • Anal cancer
  • Conditional survival
  • Outcomes tools
  • Survivorship

ASJC Scopus subject areas

  • Gastroenterology

Cite this

Conditional Survival in Anal Carcinoma Using the National Population-Based Survey of Epidemiology and End Results Database (1988-2012). / Kim, Ellen; Kim, Jong S.; Choi, Mehee; Thomas, Charles.

In: Diseases of the Colon and Rectum, Vol. 59, No. 4, 01.04.2016, p. 291-298.

Research output: Contribution to journalArticle

@article{f90735cd0f94419bbc4d630c36c3aa64,
title = "Conditional Survival in Anal Carcinoma Using the National Population-Based Survey of Epidemiology and End Results Database (1988-2012)",
abstract = "BACKGROUND: Conditional survival can provide valuable information for both patients and healthcare providers about the changing prognosis in surviving patients over time. OBJECTIVE: This study estimated conditional survival for patients with anal cancer in the United States through analysis of a national population-based cancer registry. DESIGN: Log-rank test identified significant covariates of cause-specific survival (defined as time from diagnosis until death from anal cancer). Significant covariates were considered in the multivariable regression of cause-specific survival using Cox proportional hazards models. SETTINGS: Covariates included cancer stage and demographic variables. PATIENTS: Patients in Surveillance, Epidemiology, and End Results regions diagnosed with anal squamous cell carcinoma as their first and only cancer diagnosis from 1988 to 2012 were selected from this database, and 5145 patients were included in the retrospective cohort study. MAIN OUTCOME MEASURE: Five-year conditional survival stratified by each variable in the final Cox models was measured RESULTS: The final multivariable models of overall and cause-specific survivals included stage, grade, sex, age, race, and relationship status. Over the first 6 years after diagnosis, conditional survival of distant stage increased from 37{\%} to 89{\%}, whereas regional stage increased from 65{\%} to 93{\%} and localized stage increased from 84{\%} to 96{\%}. The other variables had increasing prognosis as well, but the subgroups increased at a more similar rate over time. LIMITATIONS: The data source used does not include information on chemotherapy treatment, patient comorbidities, or socioeconomic status. CONCLUSIONS: Conditional survival showed improvement over time. Patients with advanced stage had the greatest improvement in conditional survival. This is the first study to provide specific conditional survival probabilities for patients with anal cancer.",
keywords = "Anal cancer, Conditional survival, Outcomes tools, Survivorship",
author = "Ellen Kim and Kim, {Jong S.} and Mehee Choi and Charles Thomas",
year = "2016",
month = "4",
day = "1",
doi = "10.1097/DCR.0000000000000555",
language = "English (US)",
volume = "59",
pages = "291--298",
journal = "Diseases of the Colon and Rectum",
issn = "0012-3706",
publisher = "Lippincott Williams and Wilkins",
number = "4",

}

TY - JOUR

T1 - Conditional Survival in Anal Carcinoma Using the National Population-Based Survey of Epidemiology and End Results Database (1988-2012)

AU - Kim, Ellen

AU - Kim, Jong S.

AU - Choi, Mehee

AU - Thomas, Charles

PY - 2016/4/1

Y1 - 2016/4/1

N2 - BACKGROUND: Conditional survival can provide valuable information for both patients and healthcare providers about the changing prognosis in surviving patients over time. OBJECTIVE: This study estimated conditional survival for patients with anal cancer in the United States through analysis of a national population-based cancer registry. DESIGN: Log-rank test identified significant covariates of cause-specific survival (defined as time from diagnosis until death from anal cancer). Significant covariates were considered in the multivariable regression of cause-specific survival using Cox proportional hazards models. SETTINGS: Covariates included cancer stage and demographic variables. PATIENTS: Patients in Surveillance, Epidemiology, and End Results regions diagnosed with anal squamous cell carcinoma as their first and only cancer diagnosis from 1988 to 2012 were selected from this database, and 5145 patients were included in the retrospective cohort study. MAIN OUTCOME MEASURE: Five-year conditional survival stratified by each variable in the final Cox models was measured RESULTS: The final multivariable models of overall and cause-specific survivals included stage, grade, sex, age, race, and relationship status. Over the first 6 years after diagnosis, conditional survival of distant stage increased from 37% to 89%, whereas regional stage increased from 65% to 93% and localized stage increased from 84% to 96%. The other variables had increasing prognosis as well, but the subgroups increased at a more similar rate over time. LIMITATIONS: The data source used does not include information on chemotherapy treatment, patient comorbidities, or socioeconomic status. CONCLUSIONS: Conditional survival showed improvement over time. Patients with advanced stage had the greatest improvement in conditional survival. This is the first study to provide specific conditional survival probabilities for patients with anal cancer.

AB - BACKGROUND: Conditional survival can provide valuable information for both patients and healthcare providers about the changing prognosis in surviving patients over time. OBJECTIVE: This study estimated conditional survival for patients with anal cancer in the United States through analysis of a national population-based cancer registry. DESIGN: Log-rank test identified significant covariates of cause-specific survival (defined as time from diagnosis until death from anal cancer). Significant covariates were considered in the multivariable regression of cause-specific survival using Cox proportional hazards models. SETTINGS: Covariates included cancer stage and demographic variables. PATIENTS: Patients in Surveillance, Epidemiology, and End Results regions diagnosed with anal squamous cell carcinoma as their first and only cancer diagnosis from 1988 to 2012 were selected from this database, and 5145 patients were included in the retrospective cohort study. MAIN OUTCOME MEASURE: Five-year conditional survival stratified by each variable in the final Cox models was measured RESULTS: The final multivariable models of overall and cause-specific survivals included stage, grade, sex, age, race, and relationship status. Over the first 6 years after diagnosis, conditional survival of distant stage increased from 37% to 89%, whereas regional stage increased from 65% to 93% and localized stage increased from 84% to 96%. The other variables had increasing prognosis as well, but the subgroups increased at a more similar rate over time. LIMITATIONS: The data source used does not include information on chemotherapy treatment, patient comorbidities, or socioeconomic status. CONCLUSIONS: Conditional survival showed improvement over time. Patients with advanced stage had the greatest improvement in conditional survival. This is the first study to provide specific conditional survival probabilities for patients with anal cancer.

KW - Anal cancer

KW - Conditional survival

KW - Outcomes tools

KW - Survivorship

UR - http://www.scopus.com/inward/record.url?scp=84962579809&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84962579809&partnerID=8YFLogxK

U2 - 10.1097/DCR.0000000000000555

DO - 10.1097/DCR.0000000000000555

M3 - Article

C2 - 26953987

AN - SCOPUS:84962579809

VL - 59

SP - 291

EP - 298

JO - Diseases of the Colon and Rectum

JF - Diseases of the Colon and Rectum

SN - 0012-3706

IS - 4

ER -